This is Dr. Stephen Black, cell and molecular physiologist at the Medical College of Georgia at Georgia Regents University. Credit: Phil Jones
A bacterial infection can throw off the equilibrium between two key proteins in the lungs and put patients at risk for a highly lethal acute lung injury, researchers report.
Bacteria can alter a single amino acid in the protein RhoA, pushing its activity level well above that of Rac1 and prompting blood vessels to leak and flood thousands of tiny air sacs in the lungs, said Dr. Stephen Black, cell and molecular physiologist at the Medical College of Georgia at Georgia Regents University.
The study in The Journal of Biological Chemistry also proposes a biological shield that appears to protect RhoA from the potentially lethal alteration.
"Activation of RhoA appears to be an early, early event and it's a pathologic activation," Black said. "The cell can't regulate it anymore. It just stays on," he said, comparing the aberrant activity level to a rapid-fire gun with no pause for reload.
Causes of acute lung injury include common bacterial infections that cause maladies such as pneumonia; severe trauma that induces shock; multiple transfusions; burns; and meconium aspiration, when newborns inhale waste products. Mechanical ventilation used to support ailing lungs can also cause or compound the problem that occurs in about 150,000 Americans annually, killing about one-third, and leaving many with damaged lungs.
While overactive RhoA was believed to be a culprit, just how it contributed was unknown. Researchers also knew that nitration – adding a nitro group to a protein to change its function – occurs at high rates in acute lung injury and normalizes when the stimulus, such as a bacterium, is removed.
Using human lung cells and mass spectrometry, they found the amino acid Y34 was altered in this condition. Then, using 3-D computer modeling, they mapped out exactly how that alteration affects RhoA function. They found it turns RhoA into a steady-firing protein.
While antibiotics can wipe out the bacterial stimulus, patients must survive long enough for the body to resume making normal RhoA. "This is one of the insidious things. You can clear the bacterial infection and still die," Black said. The good news is that the proteins turn over in just a few days.
Nitration occurs, in this case, when peroxynitrite is added to a protein, a move previously believed lethal to the protein. However, MCG researchers found nitration can also activate RhoA.
Once they found the specific modification, they designed a peptide that mimics the normal protein sequence and placed it on top of the area of nitration. "Think about it as a shield," Black said. For these early experiments, researchers gave the peptide shield before the stimulus to see if they were even on the right track. They've since redesigned the peptide to reduce undesirable effects on normal RhoA signaling and are now giving it the way patients may one day get it: after changes to Y34 already have occurred. "We have high hopes for what we call the gen-2 peptide," said Black, citing early evidence that it can normalize RhoA activity.
Y34 is one of about 200 amino acids in RhoA. "We are looking at one amino acid in one protein in an extraordinarily complex disease and it makes it better," said Black.
To ensure tight regulation of the consistency of blood vessel walls, Rac1 and RhoA normally have the opposing functions of pulling together and pushing apart the endothelial cells that line them. "The balance of those determines whether you are going to be tight or leaky," Black said. "If you can clear the stimulus, you can theoretically make the cells knit back together again."
Still unclear is how long RhoA can sustain its bacteria-modified super-pace and whether non-bacterial causes of acute lung injury prompt the exact RhoA alteration.
The researchers performed simultaneous studies in an animal model. The research was funded by a National Institutes of Health Program Project grant.
Explore further: Study identifies essential molecule in formation of differentiated blood cells
Medical Xpress on facebook
Related Stories
Study identifies essential molecule in formation of differentiated blood cells
Oct 07, 2013
New research in the Journal of Experimental Medicine identifies a protein that controls the formation of different types of mature blood cells – a finding that could be important to developing new treatments for blood ...
Better treatment sought for acute lung injury
Aug 22, 2011
Patients can essentially drown in their own fluids when trauma and infection prompt blood vessels to leak, flooding millions of air sacs in their lungs.
Rock And Rho: Proteins that help cancer cells groove
Dec 26, 2013
Biologists at The Johns Hopkins University have discovered that low oxygen conditions, which often persist inside tumors, are sufficient to initiate a molecular chain of events that transforms breast cancer ...
Researchers use new molecular inhibitors to successfully hit difficult cancer target
Feb 05, 2013
Early laboratory tests are the first to successfully use an experimental molecular therapy to block a hard-to-target part of a protein complex linked to several types of invasive cancer.
Spread of cancer cells may be slowed by targeting of protein
Dec 18, 2012
(Medical Xpress)—The spread of cancer cells may be slowed by targeting the protein km23-1, according to researchers at Penn State College of Medicine.
Recommended for you
Shaped scaffolding helps repair mandibular bone
3 hours ago
A new invention made at the Faculty of Dentistry, University of Oslo, Norway, helps the body generate new bone which is as strong as the original.
Sepsis study comparing three treatment methods shows same survival rate
8 hours ago
Survival of patients with septic shock was the same regardless of whether they received treatment based on specific protocols or the usual high-level standard of care, according to a five-year clinical study. The large-scale ...
Baby's life saved after 3D printed devices were implanted at U-M to restore his breathing
18 hours ago
In his 18 months of life, Garrett Peterson has never gone home, spending his days in hospital beds tethered to ventilators that even at the highest settings couldn't prevent his breathing from periodically ...
Eat more, die young: Why eating a diet very low in nutrients can extend lifespan
18 hours ago
A new evolutionary theory in BioEssays claims that consuming a diet very low in nutrients can extend lifespan in laboratory animals, a finding which could hold clues to promoting healthier ageing in humans.
Biomarkers provide potential for better preeclampsia detection
19 hours ago
Identifying biomarkers could lead to earlier detection of preeclampsia, which in turn can lead to healthier mothers and children, according to a collaborative study from the Centre of Molecular Inflammation Research (CEMIR) ...
Engineered bacteria sense, remember, and report on their experience in the gut
21 hours ago
It's a jungle in there. In the tightly woven ecosystem of the human gut, trillions of bacteria compete with each other on a daily basis while they sense and react to signals from the immune system, ingested ...
User comments
© Medical Xpress 2011-2014, Science X network
This is Dr. Stephen Black, cell and molecular physiologist at the Medical College of Georgia at Georgia Regents University. Credit: Phil Jones
A bacterial infection can throw off the equilibrium between two key proteins in the lungs and put patients at risk for a highly lethal acute lung injury, researchers report.
Bacteria can alter a single amino acid in the protein RhoA, pushing its activity level well above that of Rac1 and prompting blood vessels to leak and flood thousands of tiny air sacs in the lungs, said Dr. Stephen Black, cell and molecular physiologist at the Medical College of Georgia at Georgia Regents University.
The study in The Journal of Biological Chemistry also proposes a biological shield that appears to protect RhoA from the potentially lethal alteration.
"Activation of RhoA appears to be an early, early event and it's a pathologic activation," Black said. "The cell can't regulate it anymore. It just stays on," he said, comparing the aberrant activity level to a rapid-fire gun with no pause for reload.
Causes of acute lung injury include common bacterial infections that cause maladies such as pneumonia; severe trauma that induces shock; multiple transfusions; burns; and meconium aspiration, when newborns inhale waste products. Mechanical ventilation used to support ailing lungs can also cause or compound the problem that occurs in about 150,000 Americans annually, killing about one-third, and leaving many with damaged lungs.
While overactive RhoA was believed to be a culprit, just how it contributed was unknown. Researchers also knew that nitration – adding a nitro group to a protein to change its function – occurs at high rates in acute lung injury and normalizes when the stimulus, such as a bacterium, is removed.
Using human lung cells and mass spectrometry, they found the amino acid Y34 was altered in this condition. Then, using 3-D computer modeling, they mapped out exactly how that alteration affects RhoA function. They found it turns RhoA into a steady-firing protein.
While antibiotics can wipe out the bacterial stimulus, patients must survive long enough for the body to resume making normal RhoA. "This is one of the insidious things. You can clear the bacterial infection and still die," Black said. The good news is that the proteins turn over in just a few days.
Nitration occurs, in this case, when peroxynitrite is added to a protein, a move previously believed lethal to the protein. However, MCG researchers found nitration can also activate RhoA.
Once they found the specific modification, they designed a peptide that mimics the normal protein sequence and placed it on top of the area of nitration. "Think about it as a shield," Black said. For these early experiments, researchers gave the peptide shield before the stimulus to see if they were even on the right track. They've since redesigned the peptide to reduce undesirable effects on normal RhoA signaling and are now giving it the way patients may one day get it: after changes to Y34 already have occurred. "We have high hopes for what we call the gen-2 peptide," said Black, citing early evidence that it can normalize RhoA activity.
Y34 is one of about 200 amino acids in RhoA. "We are looking at one amino acid in one protein in an extraordinarily complex disease and it makes it better," said Black.
To ensure tight regulation of the consistency of blood vessel walls, Rac1 and RhoA normally have the opposing functions of pulling together and pushing apart the endothelial cells that line them. "The balance of those determines whether you are going to be tight or leaky," Black said. "If you can clear the stimulus, you can theoretically make the cells knit back together again."
Still unclear is how long RhoA can sustain its bacteria-modified super-pace and whether non-bacterial causes of acute lung injury prompt the exact RhoA alteration.
The researchers performed simultaneous studies in an animal model. The research was funded by a National Institutes of Health Program Project grant.
Explore further: Study identifies essential molecule in formation of differentiated blood cells
Medical Xpress on facebook
Related Stories
Study identifies essential molecule in formation of differentiated blood cells
Oct 07, 2013
New research in the Journal of Experimental Medicine identifies a protein that controls the formation of different types of mature blood cells – a finding that could be important to developing new treatments for blood ...
Better treatment sought for acute lung injury
Aug 22, 2011
Patients can essentially drown in their own fluids when trauma and infection prompt blood vessels to leak, flooding millions of air sacs in their lungs.
Rock And Rho: Proteins that help cancer cells groove
Dec 26, 2013
Biologists at The Johns Hopkins University have discovered that low oxygen conditions, which often persist inside tumors, are sufficient to initiate a molecular chain of events that transforms breast cancer ...
Researchers use new molecular inhibitors to successfully hit difficult cancer target
Feb 05, 2013
Early laboratory tests are the first to successfully use an experimental molecular therapy to block a hard-to-target part of a protein complex linked to several types of invasive cancer.
Spread of cancer cells may be slowed by targeting of protein
Dec 18, 2012
(Medical Xpress)—The spread of cancer cells may be slowed by targeting the protein km23-1, according to researchers at Penn State College of Medicine.
Recommended for you
Shaped scaffolding helps repair mandibular bone
3 hours ago
A new invention made at the Faculty of Dentistry, University of Oslo, Norway, helps the body generate new bone which is as strong as the original.
Sepsis study comparing three treatment methods shows same survival rate
8 hours ago
Survival of patients with septic shock was the same regardless of whether they received treatment based on specific protocols or the usual high-level standard of care, according to a five-year clinical study. The large-scale ...
Baby's life saved after 3D printed devices were implanted at U-M to restore his breathing
18 hours ago
In his 18 months of life, Garrett Peterson has never gone home, spending his days in hospital beds tethered to ventilators that even at the highest settings couldn't prevent his breathing from periodically ...
Eat more, die young: Why eating a diet very low in nutrients can extend lifespan
18 hours ago
A new evolutionary theory in BioEssays claims that consuming a diet very low in nutrients can extend lifespan in laboratory animals, a finding which could hold clues to promoting healthier ageing in humans.
Biomarkers provide potential for better preeclampsia detection
19 hours ago
Identifying biomarkers could lead to earlier detection of preeclampsia, which in turn can lead to healthier mothers and children, according to a collaborative study from the Centre of Molecular Inflammation Research (CEMIR) ...
Engineered bacteria sense, remember, and report on their experience in the gut
21 hours ago
It's a jungle in there. In the tightly woven ecosystem of the human gut, trillions of bacteria compete with each other on a daily basis while they sense and react to signals from the immune system, ingested ...
User comments
© Medical Xpress 2011-2014, Science X network
0 comments:
Post a Comment